v3.26.1
Stock-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2026
Stock-Based Compensation [Abstract]  
Schedule of Stock Option Activity

Stock option activity under the Plan during the three months ended March 31, 2026 was as follows:

 

    Number of Options     Weighted Average Exercise Price (Per Share)     Weighted- Average Remaining  Life (Years)     Aggregate Intrinsic Value  
Outstanding at December 31, 2025     2,094,080     $ 5.73             $ 34,460  
Retroactive application of recapitalization     4,400,730       (3.88 )                
Outstanding at December 31, 2025, as adjusted     6,494,810       1.85               34,460  
Granted     1,680,541       8.47                  
Exercised     (406,385 )     0.56               3,058  
Expired     (389,227 )     2.35                  
Forfeited     (26,288 )     4.59                  
Outstanding at March 31, 2026     7,353,451       3.40       7.1       29,046  
Exercisable at March 31, 2026     4,549,732     $ 1.59       5.8     $ 26,206  
Schedule of Fair Value of The Stock-Based Awards

The following table provides the assumptions used in determining the fair value of the stock-based awards:

 

   

Three Months Ended

March 31,

  
    2026     2025  
Risk-free interest rate     3.89 %     4.01%-4.06 %
Expected dividend yield     — %     — %
Expected volatility     42.25 %     45.67%-47.475 %
Expected life in years     5.50       5.18-5.99  
Fair value of Common Stock   $ 11.73       $3.60-$3.77  
Schedule of Consolidated Statements of Operations

Total stock-based compensation expense as presented within the consolidated statements of operations was as follows:

 

    Three Months Ended
March 31,		  
    2026     2025  
Cost of revenue   $ 241     $ 50  
Research and development     856       385  
General and administrative     189       74  
Selling and marketing     8       4  
Total   $ 1,295     $ 513